Dihydroimidazothiazole derivatives

Disclosed are dihydroimidazothiazole derivative compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein the variables are as defined in the specification. These compounds exhibit 5-HT1A agonism in addition to noradrenaline reuptake inhibition and optionally also 5-HT reuptake...

Full description

Saved in:
Bibliographic Details
Main Authors ROWLEY, ROBERT JOHN, DAWSON, GRAHAM JOHN, SMYTH, DONALD, BARBA, OSCAR, THOMAS, GERARD HUGH, KRULLE, THOMAS MARTIN
Format Patent
LanguageEnglish
Published 25.06.2010
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Disclosed are dihydroimidazothiazole derivative compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein the variables are as defined in the specification. These compounds exhibit 5-HT1A agonism in addition to noradrenaline reuptake inhibition and optionally also 5-HT reuptake inhibition, and are useful for the treatment of obesity.
Bibliography:Application Number: NZ20060561006